Envision Healthcare Corporation (NYSE:EVHC) reported Q2 2017 earnings this Afternoon, coming in at $0.85 per share, beating Wall Street’s estimates of $0.75 per Share. Revenue for the quarter came in at $1.95 billion missing the streets estimates of $1.96 billion
Analyst Coverage For Envision Healthcare Corporation (NYSE:EVHC)
These are 1 Hold Rating, 9 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Envision Healthcare Corporation (NYSE:EVHC) is Buy (Score: 3.00) with a consensus target price of $72.13 , a potential (31.02% upside)Recent Insider Trading for Envision Healthcare Corporation (NYSE:EVHC)
- On 7/3/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $62.69 per share and the total transaction amounting to $94,035.00.
- On 6/22/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $60.00 per share and the total transaction amounting to $90,000.00.
- On 5/3/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $60.53 per share and the total transaction amounting to $90,795.00.
- On 4/3/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $61.34 per share and the total transaction amounting to $92,010.00.
- On 3/10/2017 John Thomas Gawaluck, Director, bought 1,500 with an average share price of $66.65 per share and the total transaction amounting to $99,975.00.
- On 3/1/2017 Robert Jon Coward, Insider, sold 1,500 with an average share price of $65.00 per share and the total transaction amounting to $97,500.00.
Recent Trading for Envision Healthcare Corporation (NYSE:EVHC) Shares of Envision Healthcare Corporation closed the previous trading session at 55.05 down -0.74 -1.33% with 2,272,792 shares trading hands.